The Exchange has received the disclosure under Regulation 29(1) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nippon India Mutual Fund
SANOFICONR · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Nippon India Mutual Fund has disclosed an open market acquisition of 30,000 equity shares (0.1303%) of Sanofi Consumer Healthcare India Ltd between June 14, 2024 and April 29, 2026. The fund's total holding has risen from 11,32,073 shares (4.9155%) to 11,62,073 shares (5.0458%), crossing the 5% regulatory threshold. The acquisition was made through Nippon Life India Trustee Limited in the open market. The acquirer explicitly stated it does not belong to the promoter/promoter group. The company's total share capital is Rs 23,03,06,220 comprising 2,30,30,622 shares of Rs 10 face value each.
The crossing of the 5% threshold triggers SEBI's creeping acquisition disclosure norms. This represents institutional accumulation rather than promoter activity, and may signal positive sentiment from a major mutual fund towards the company.